Refine by
Drug Development Articles & Analysis
677 news found
Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the ...
Watertown, MA - June 29, 2025 - Biopharma PEG, a leading innovator in high-quality polyethylene glycol (PEG) derivatives, today announced it has successfully obtained Drug Master File (DMF) approval from the U.S. Food and Drug Administration (FDA) for its self-developed HZ-PEG-HZ (1K) product. ...
Versatile compound shows promise in drug synthesis, metal chelation, antioxidant activity, and moreChangsha, China – May 22, 2025– Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers and pharmaceutical ...
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the expansion and enhancement of its comprehensive Drug Discovery Services to help scientists advance antiviral therapeutic development, including target selection and validation, hit selection and optimization, and preclinical ...
The N-terminal Edman Degradation technique, developed by Pehr Edman in the 1950s, remains a cornerstone of protein sequencing. ...
” She emphasized that understanding these metabolic processes not only aids in identifying biomarkers for diseases but also helps in the development of targeted therapies and optimization of bioproduction processes. ...
Key Product Highlights: · PEG Derivatives o A vast inventory of over 3000 high-quality PEG derivatives. o Monodispersed PEG linkers and multi-arm PEGs. o Scalable production from R&D to GMP commercial levels. o Applications spanning ADCs, PROTACs, LNP drug delivery, medical devices, and more. · Pharmaceutical Intermediates o Comprehensive process ...
Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of ...
As a specialist in regulatory matters, Proregulations has extensive experience in the registration of drugs in the EU, supporting its clients at all stages from drug development to market access. Proregulations is familiar with the MAA approval process, provides detailed interpretation and advice on EU drugs regulations, and ...
In dermatology, new methods for treating benign epidermal lesions are emerging, alongside the development of drug-free therapies to enhance patient well-being. Surgical innovations, such as advanced transplant surgery instruments and bone cement applications, are optimizing complex procedures. ...
As the prevalence of diabetes continues to rise, there is an urgent need for advanced research models that can accurately simulate the disease and facilitate the development of effective interventions. Ace Therapeutics’ in vivo models such as diabetes spontaneous models are made to mimic the pathophysiological characteristics of Type 1 and Type 2 diabetes mellitus, ...
In today’s evolving pharmaceutical landscape, the search for new drug delivery systems (DDS) is of paramount importance to improving therapeutic outcomes. ...
(Huateng Pharma), a global leader in the development and production of high-quality PEG derivatives, is pleased to announce that its mPEG-pALD (20K) has successfully completed its Drug Master File (DMF) filing with the U.S. ...
“This achievement demonstrates our commitment to providing our customers with the highest quality materials for their drug development programs. We are confident that this registration will help to streamline and accelerate the development of new ...
Since its inception, CD Bioparticles has been committed to developing and providing cutting-edge technologies to advance drug discovery and development. ...
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...
In medical applications, they’re used in cancer therapies and viral infection drugs. Alfa Chemistry makes this possible by providing pure and highly diverse nucleosides with modified versions used in the development of oligonucleotide therapeutics. ...
These APIs are mostly regulators of neurotransmitters such as dopamine and serotonin, which are central to mental stability. These range from conventional drugs such as chlorpromazine and haloperidol, to noveler ones such as aripiprazole. ...
CD Formulation’s commitment to innovation is evident in their comprehensive suite of services, meticulously designed to meet the unique needs of researchers focusing on drug development and delivery. One of the cornerstones of CD Formulation’s technological prowess lies in solvent casting. ...
During this promotional period, customers will benefit from CD Formulation’s experience in formulation development and drug analysis to get a better outcome in their research projects. The offer incorporates a wide range of services, including transdermal patch development, a major service where CD Formulation shines by providing custom ...